DxPartner was established in 2020. Its predecessor can be traced back to 2004. The founder and his entrepreneurship team have more than 20 years professional background and comprehensive experience in IVD Assay Development, Scale Up, Manufacturing, Registration and even one-stop enablement service. Over the past 20 years, DxPartner has served many IVD manufacturers, with customers all over the world, and successfully enabled many listed IVD companies.
DxPartner is a science-based, technology-driven Contract Development Organization (CDMO business) focusing on IVD industry. Adhering to the service concept of Innovation driven and customer-centric, it is committed to providing comprehensive and high-quality outsourcing assay development, process validation and scale up technical consulting and contract manufacturing services for IVD and biotechnology companies worldwide. ultimately DxPartner is going to building a better symbosiscommunity for IVD industry.
The company's business covers POCT, immunoassay, molecular diagnostics, clinical chemistry, animal diagnostics and many other subsegment of IVD applications. From raw material selection & screening, raw material customization, intermediate development & manufacturing, kit/assay development, scale-up technical consulting, outsourcing manufacturing & contract registration service, the company provides customers with one-stop solution of full capability in outsourcing services for IVD industry. Through professional "CDMO" business models, DxPartner continuously simplified customer R&D process, shorten customer R&D project cycle, endorsed customers on improving their R&D efficiency, provided strategic endorsement to the R&D department of IVD manufacturers, reduced customer operational cost and risks, and enabled customers to achieve outstanding commercial success earlier. Currently, DxPartner has shaped a complete closed loop of IVD industrial chain, including independent innovation on critical core raw materials, contract assay development (CDO), contract manufacturing (CMO), contract registration (CRO), and technical consulting services. It is an important strategic partner of IVD manufacturer and related affiliated enterprises.
The corporate vision of DxPartner is "Scientific and technological innovation promotes people living in a healthy life". The company is committed to bringing more novel technologies to benefit global patients by enabling IVD industry clusters, so as to promote the healthy development of in vitro diagnostic industry and accelerate the realization of the brilliant future of human healthy life.
The voice of the customer
During the global pandemic of COVID, DxPartner made full use of
its own talent strength, strictly screened the critical raw materials, and expanded the track and optimized the products for various
enterprises in the IVD industry with exquisite technology andexpertise. It has a very deep cooperation with many a lot IVD
enterprises, and has accumulated profound experience in the
industry. In the post-epidemic era, the macro-enviroment of both
domestic and international market are getting more and more
complicated and IVD mnuafactuers are also facing increasingly
challenges due to the implementation of centralized procurement
policy from China Government. It is in urgent need of high-quality
CDMO partners such as DxPartner to further optimize our strategic
layout, quickly and accurately making decision and driving strategic
direction optimization, so as to escort the fast development of our
enterprises!
-Jiang Xiwen (Deputy General Manager, Chief Scientist, R & D
Director, senior engineer) " of Guangzhou Da'an Gene Co., Ltd
"
